Inventor · disambiguated record
Lee Patient
Also filed as: PATIENT LEE
17 granted patents·8 pending applications·70 citations·filing 2004–2022
93Inventor score
Files withPROXIMAGEN LLC12PROXIMAGEN LTD6BENEVOLENTAI CAMBRIDGE LTD3AMURA THERAPEUTICS LTD1HAMLYN RICHARD J1
Top patents by PatentIndex Score
25 records- 0191US9951068B2Imidazo[4,5-C]pyridine and pyrrolo[2,3-C]pyridine derivatives as SSAO inhibitorsPROXIMAGEN LTD·Filed 2017·Granted Apr 24, 2018·8 cites·21 claims
- 0291US9676769B2Imidazo[4,5-C]pyridine and pyrrolo[2,3-C]pyridine derivatives as SSAO inhibitorsPROXIMAGEN LTD·Filed 2014·Granted Jun 13, 2017·11 cites·9 claims
- 0391US9428498B2Substituted imidazo[4,5-c]pyridine compounds and compositions thereofPROXIMAGEN LTD·Filed 2014·Granted Aug 30, 2016·11 cites·16 claims
- 0490US10428066B2Imidazo[4,5-C]pyridine and pyrrolo[2,3-C]pyridine derivatives as SSAO inhibitorsPROXIMAGEN LLC·Filed 2018·Granted Oct 1, 2019·6 cites·25 claims
- 0588US10995091B2CXCR4 receptor antagonistsPROXIMAGEN LLC·Filed 2018·Granted May 4, 2021·3 cites·14 claims
- 0686US10968223B2Imidazo[4,5-c]pyridine and pyrrolo[2,3-c]pyridine derivatives as SSAO inhibitorsPROXIMAGEN LLC·Filed 2020·Granted Apr 6, 2021·1 cites·24 claims
- 0785US10590125B2CompoundsPROXIMAGEN LLC·Filed 2016·Granted Mar 17, 2020·3 cites·9 claims
- 0885US10155761B2CXCR4 receptor antagonistsPROXIMAGEN LLC·Filed 2017·Granted Dec 18, 2018·4 cites·16 claims
- 0984US11512082B2Substituted imidazo[4,5-c]pyridine compounds and compositions thereofPROXIMAGEN LLC·Filed 2020·Granted Nov 29, 2022·1 cites·20 claims
- 1083US10065954B2Substituted imidazo[4,5-c]pyridines as SSAO inhibitorsPROXIMAGEN LTD·Filed 2015·Granted Sep 4, 2018·5 cites·17 claims
- 1183US9353086B2CXCR4 receptor antagonistsSAVORY EDWARD DANIEL·Filed 2011·Granted May 31, 2016·6 cites·17 claims
- 1282US2023110165A1Substituted Imidazo[4,5-c]pyridine Compounds and Compositions ThereofPROXIMAGEN LLC·Filed 2022·Application pending·0 cites
- 1381US9580415B2CompoundsPROXIMAGEN LTD·Filed 2014·Granted Feb 28, 2017·9 cites·20 claims
- 1480US10766897B2Imidazo[4,5-c]pyridine and pyrrolo[2,3-c]pyridine derivatives as SSAO inhibitorsPROXIMAGEN LLC·Filed 2019·Granted Sep 8, 2020·1 cites·27 claims
- 1572US2022348577A1CXCR4 Receptor AntagonistsPROXIMAGEN LLC·Filed 2021·Application pending·0 cites
- 1667US11530208B2Imidazo[4,5-C]pyridine derived SSAO inhibitorsPROXIMAGEN LLC·Filed 2015·Granted Dec 20, 2022·1 cites·16 claims
- 1758US2021024518A1Therapeutic compound and use in therapyPROXIMAGEN LLC·Filed 2020·Application pending·0 cites
- 1853US2016046606A1CXCR4 Receptor AntagonistsPROXIMAGEN LTD·Filed 2015·Application pending·0 cites
- 1952US10738044B2Therapeutic compound and use in therapyPROXIMAGEN LLC·Filed 2016·Granted Aug 11, 2020·0 cites·3 claims
- 2052US2007043024A1Azacyclic compounds as inhibitors of sensory neurone specific channelsHAMLYN RICHARD J·Filed 2004·Application pending·0 cites
- 2150US10988473B2Process for the preparation of (3S,4S)-tetrahydrofuran-3-yl 4-isopropyl-6,7-dihydro-3H-imidazo[4,5-C]pyridine-5(4H)-carboxylateBENEVOLENTAI CAMBRIDGE LTD·Filed 2017·Granted Apr 27, 2021·0 cites·20 claims
- 2249US2024343729A1Imidazole organic compounds and their use against inflammatory bowel diseaseBENEVOLENTAI CAMBRIDGE LTD·Filed 2022·Application pending·0 cites
- 2349US2024336591A1Organic pyridine-pyrazole compounds and their usesBENEVOLENTAI CAMBRIDGE LTD·Filed 2022·Application pending·0 cites
- 2448US8039641B2Tetrahydrofuro[3,2-b] pyrrol-3-one intermediatesAMURA THERAPEUTICS LTD·Filed 2009·Granted Oct 18, 2011·0 cites·6 claims
- 2544US2009131502A1Biologically active compoundsQUIBELL MARTIN·Filed 2008·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Lee Patient files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →